+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Association of Adverse Perinatal Events with an Empty Sella turcica in Children with Growth Hormone Deficiency

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          High-resolution computed tomography (HR-CT) of the hypothalamo-pituitary region was performed in 26 consecutive children presenting with growth hormone deficiency (GHD) at one clinic. 58% had an empty sella turcica (ES) and 42% a full sella turcica (FS). There was no difference between the ES and FS groups for mean ( ± 95% confidence limits) presentation age (ES 6.7 ( ± 1.8) years, FS 5.6 ( ± 2.2) years), height standard deviation score (SDS) (ES -3.9 ( ± 0.8), FS -3.3 ( ± 0.5)) nor head circumference SDS (ES -1.9 ( ± 1.1), FS -0.7 ( ± 1.1)). There were significant associations between the ES group and a history of adverse perinatal events (p < 0.001) and multiple pituitary deficiency (p = 0.014). Growth hormone response to an acute growth hormone releasing factor test showed no association with HR-CT diagnosis. Sella turcica volumes were calculated from the HR-CT scans. All sella volumes were small; mean SDS for height was -2.6 ( ± 0.2). There was no difference in sella volume SDS between the ES and FS groups (ES -2.9 ( ± 0.3), FS -2.5 ( ± 0.4)). Adverse perinatal events may cause an ES and GHD by compromising the blood supply to the pituitary gland or infundibulum.

          Related collections

          Author and article information

          Horm Res Paediatr
          Hormone Research in Paediatrics
          S. Karger AG
          28 November 2008
          : 28
          : 1
          : 5-12
          Departments of Child Health and Diagnostic Radiology, University of Manchester School of Medicine, Manchester, UK
          180918 Horm Res 1987;28:5–12
          © 1987 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 8
          Pediatric Endocrinology


          Comment on this article